Company Expresses Comfort with 3Q and Full Year 2009 External
Expectations
Regulatory News:
Colgate-Palmolive Company (NYSE:CL) today reported record net income and
diluted earnings per share in second quarter 2009 of $561.6 million and
$1.07, respectively. Second quarter 2008 reported net income and diluted
earnings per share were $493.8 million and $.92, respectively, which
included $29.5 million of aftertax charges ($.06 per diluted share)
related to the 2004 Restructuring Program. Excluding restructuring
charges (which pertain only to 2008), net income and diluted earnings
per share increased 7% and 9%, respectively.
Worldwide sales declined 5.5% during the second quarter to $3,745.0
million and unit volume declined 1.5%. Organic sales (excluding foreign
exchange, acquisitions and divestments) grew 6.0%. Global pricing
increased 7.5% and foreign exchange was negative 11.5%.
Gross profit margin as reported increased to 58.8% in second quarter
2009 from 56.5% in the year ago period. Excluding restructuring charges
in 2008, gross profit margin increased 200 basis points to 58.8% in
second quarter 2009 from 56.8% in second quarter 2008, reflecting the
benefits of increased pricing and cost-savings programs, which more than
offset the impact of negative foreign exchange.
Selling, general and administrative expenses were 34.6% and 35.9% of net
sales in second quarter 2009 and 2008, respectively. Excluding
restructuring charges in 2008, selling, general and administrative
expenses decreased to 34.6% of net sales in second quarter 2009 from
35.4% of net sales in second quarter 2008. Worldwide advertising costs
declined 120 basis points as a percentage to sales versus the year ago
period to 10.5%, brought about by lower media rates in most areas of the
world and reduced levels of spending in line with competition.
Operating profit was $887.1 million in second quarter 2009 compared to
$788.4 million as reported in second quarter 2008. Excluding
restructuring charges in 2008, operating profit rose 7% to $887.1
million in second quarter 2009 from $827.3 million in second quarter
2008, increasing to 23.7% from 20.9% as a percent to sales.
Net cash provided by operations year to date increased by 17% to
$1,210.7 million. Working capital decreased to 3.2% of sales versus 3.6%
in the comparable 2008 period, primarily due to a reduction in
receivable days outstanding. Overall, Colgate’s balance sheet is strong
and getting stronger, with all key ratios continuing to improve.
Ian Cook, Chairman, President and Chief Executive Officer, commented on
the results excluding restructuring charges, “Given continued worldwide
economic difficulties, we are very pleased that profitability was strong
with gross profit margin, operating profit margin and net income as a
percent to sales all increasing to record levels. In addition, our
top-line growth continued with organic sales increasing a healthy 6.0%.
“We are delighted that gross profit margin increased by 200 basis points
during the quarter. This allowed for higher advertising spending behind
Colgate’s brands versus the first quarter both in absolute dollars and
as a percent to sales, which drove market share gains worldwide.
Colgate’s global toothpaste leadership strengthened to 44.8% during the
quarter with market share gains in many countries including the United
States, Mexico, Brazil, China, India and Russia. Colgate also
strengthened its global leadership in manual toothbrushes, with its
global market share in that category reaching a record 31.1% year to
date, up 0.6 share points versus year ago.”
Mr. Cook continued, “Looking ahead, the excellent gross margin should
continue in the balance of the year driven by easing raw and packaging
material costs and continued benefit from both higher prices already
implemented and our ongoing aggressive savings programs. We expect gross
profit margin should be up at or above the high end of our targeted
range of 75 to 125 basis points for the full year 2009.
“Continued gross margin increases should allow for even higher
advertising levels in the second half of the year versus the first half,
in support of a very full pipeline of innovative new products across all
price points. This should contribute to strong organic sales growth
driven by both positive volume and higher pricing.
“Overall, we are comfortable with external profit expectations for both
the third quarter and the year.”
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate
on second quarter results. To access this call as a webcast, please go
to Colgate’s web site at http://www.colgate.com.
The following are comments about divisional performance. See attached
Geographic Sales Analysis and Segment Information schedules for
additional information on divisional sales and operating profit.
North America (20% of Company Sales)
North America sales grew 2.5% in the second quarter. Unit volume
increased 2.5% with 1.5% higher pricing and 1.5% negative foreign
exchange. Organic sales grew 4.0% during the quarter. North America
operating profit increased 17% during the quarter due to new products,
cost-savings programs and lower raw and packaging material costs more
than offsetting increased advertising.
In the U.S., new product launches are contributing to market share gains
across categories. Market share gains year to date were seen in
toothpaste, manual toothbrushes, power toothbrushes, liquid hand soap,
body washes, hand dish liquid and liquid cleaners. Colgate’s toothpaste
market share reached 36.9% year to date, up 0.5 share points versus year
ago. Colgate Sensitive Enamel Protect, Colgate Max Fresh with Mouthwash
Beads and Colgate Max White with Mini Bright Strips toothpastes
contributed to the share gains. Colgate’s share of the manual toothbrush
market reached a record 32.7% year to date, up 4.8 share points versus
year ago, including new Colgate Wisp mini-brush whose market share
reached 3.9% year to date and exceeded 7% for the second quarter.
Colgate 360° Deep Clean, Colgate Max Fresh and Colgate Max White manual
toothbrushes also contributed to the share gains.
Successful new products contributing to growth in the U.S. in other
categories include Softsoap Body Butter Apricot Scrub and Irish Spring
Hair and Body and Cool Relief body washes, Softsoap Ensembles liquid
hand soap and Ajax Lime with Bleach Alternative dish liquid.
Looking ahead, new product activity in the U.S. planned for third
quarter 2009 includes Colgate 360° ActiFlex manual toothbrush with a
unique flexible bridge that gently bends and angles as you brush and
Softsoap Nutri Serums body wash infused with softening serum pearls
enriched with nutrients for soft and healthy looking skin.
Latin America (28% of Company Sales)
Latin America unit volume increased 2.0% during the quarter, primarily
led by volume gains in Brazil and Venezuela. Higher pricing added 14.5%
while foreign exchange was negative 18.0%, resulting in a sales decline
of 1.5%. Organic sales for Latin America grew 16.5% during the quarter.
Latin America operating profit increased 14% during the quarter due to
higher pricing, cost-saving initiatives and lower advertising costs,
partially offset by negative foreign exchange.
Colgate continues to build its strong leadership in oral care throughout
Latin America with its regional toothpaste market share at a record high
of 78.3% year to date, driven by market share gains in nearly every
country. Strong sales of premium-priced offerings such as Colgate
Sensitive Enamel Protect, Colgate Total Professional Sensitive and
Colgate Max Fresh Night toothpastes drove share gains throughout the
region. In Brazil, for example, Colgate’s toothpaste market share
reached 70.0% year to date, up 120 basis points versus year ago.
Colgate’s leading share of the manual toothbrush market for the region
is at a record high year to date at 41.4%, up 260 basis points versus
year ago. Strong sales of Colgate 360° Deep Clean and Colgate Max Fresh
manual toothbrushes throughout the region contributed to this success.
In other product categories, Colgate Plax Whitening and Colgate Plax
Complete Care mouthwashes, Palmolive Naturals Perfect Tone and Protex
Aloe bar soaps, Lady Speed Stick Professional Protection and Mennen Cool
Night deodorants and Suavitel Magic Moments fabric conditioner
contributed to market share gains in the region.
Europe/South Pacific (21% of Company
Sales)
As reported, Europe/South Pacific sales and unit volume declined 18.0%
and 3.0%, respectively. Excluding divested businesses, sales and unit
volume declined 17.5% and 2.5%, respectively. Pricing increased 1.0% and
foreign exchange was negative 16.0%. Organic sales for Europe/South
Pacific declined 1.5%. Volume gains in the United Kingdom and Greece
were more than offset by volume declines in France, Iberia, Poland and
the GABA business. Operating profit for the region declined 12% during
the quarter due to negative foreign exchange partially offset by lower
advertising costs.
Colgate maintained its oral care leadership in the Europe/South Pacific
region with toothpaste share gains in Germany, Greece, Switzerland,
Czech Republic and Slovakia. Successful premium products driving share
gains include Colgate Total Advanced Clean, Colgate Max White and
Colgate Sensitive Enamel Protect toothpastes. In the manual toothbrush
category, Colgate 360° Deep Clean and Colgate Max White toothbrushes
contributed to share gains in key countries throughout the region.
Recent premium innovations contributing to growth in other product
categories include Colgate Plax Alcohol Free and Colgate Plax Ice mouth
rinses, Palmolive Madagascar Sunset and Palmolive Marrakech Sunrise
shower gels and liquid hand soaps, Ajax Professional bucket dilutable
and Ajax Professional glass cleaners, Lady Speed Stick Aloe spray
deodorant and Soupline Magic Moments and Soupline Aroma Tranquility
fabric conditioners.
Greater Asia/Africa (17% of Company
Sales)
As reported, Greater Asia/Africa sales and unit volume declined 4.5% and
1.5%, respectively. Excluding divested businesses, Greater Asia/Africa
sales and unit volume declined 4.0% and 1.0%, respectively. Volume gains
in India and the Greater China region were more than offset by volume
declines in Russia, South Africa and Ukraine. Pricing increased 9.0% and
foreign exchange was negative 12.0%. Organic sales for Greater
Asia/Africa increased 8.0%. Operating profit for the region increased
14% during the quarter due to higher pricing, lower advertising costs
and lower raw and packaging material costs, partially offset by negative
foreign exchange.
Colgate maintained its toothpaste leadership in Greater Asia with market
share gains in key countries throughout the region including impressive
share gains in India, China and Russia. Successful new products driving
the share gains throughout the region include Colgate Total Professional
Clean and Colgate Sensitive Enamel Protect.
New products contributing to growth in other categories in the region
include Colgate 360° ActiFlex and Colgate Max Fresh manual toothbrushes,
Palmolive Papaya Yogurt shower gel, bar soap and liquid hand soap,
Protex Clean and Pure shower cream and bar soap and Lady Speed Stick
Pure Freshness deodorant.
Hill’s (14% of Company Sales)
Hill’s sales and unit volume declined 3.0% and 11.5%, respectively,
versus a very strong performance in the year ago quarter. Pricing
increased 12.5% and foreign exchange was negative 4.0%. Hill’s organic
sales rose 1.0% during the quarter. Volume declines were primarily
driven by a very difficult comparison with the year ago quarter due to
the timing of price increases taken. Operating profit increased 7%
during the quarter due to higher pricing, partially offset by higher raw
and packaging material costs and negative foreign exchange.
Innovative new products contributing to sales in the U.S. specialty
channel include Science Diet Nature’s Best Canine and Feline, Science
Diet Culinary Creations Feline and the relaunch of Science Diet Puppy
and Kitten dry foods with improved formulas including higher levels of
antioxidants clinically proven to build a healthier immune system within
90 days. Prescription Diet r/d and w/d Canine and Feline weight
management foods contributed to sales in the U.S. veterinary channel.
New pet food products contributing to international sales include
Science Diet Culinary Creations Feline, the relaunch of Science Diet
Puppy and Kitten foods, and Prescription Diet r/d and w/d Canine Small
Bites.
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer
products company, tightly focused on Oral Care, Personal Care, Home Care
and Pet Nutrition. Colgate sells its products in over 200 countries and
territories around the world under such internationally recognized brand
names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex,
Sorriso, Kolynos, Elmex, Tom’s of Maine, Ajax, Axion, Fabuloso, Soupline
and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription
Diet. For more information about Colgate’s global business, visit the
Company's web site at http://www.colgate.com.
Unless otherwise indicated, all market share data included in this press
release is as measured by ACNielsen.
Cautionary Statement on Forward-Looking
Statements
This press release and the related webcast (other than historical
information) may contain forward-looking statements. Such statements may
relate, for example, to sales or volume growth, organic sales growth,
profit and profit margin growth, earnings growth, financial goals,
cost-reduction plans, tax rates and new product introductions. These
statements are made on the basis of our views and assumptions as of this
time and we undertake no obligation to update these statements. We
caution investors that any such forward-looking statements are not
guarantees of future performance and that actual events or results may
differ materially from those statements. Investors should consult the
Company’s filings with the Securities and Exchange Commission (including
the information set forth under the captions “Risk Factors” and
“Cautionary Statement on Forward-Looking Statements” in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2008) for
information about certain factors that could cause such differences.
Copies of these filings may be obtained upon request from the Company’s
Investor Relations Department or the Company’s web site at http://www.colgate.com.
As required, the Company adopted Financial Accounting Standards Board
Statement No. 160, "Noncontrolling Interests in Consolidated Financial
Statements - An Amendment of ARB No. 51", on January 1, 2009. As a
result of the adoption, certain prior period amounts were reclassified
within the Condensed Consolidated Statements of Income and Balance
Sheets. While the reclassification had no impact on Net income or
earnings per common share, it did impact the previously reported
Operating profit and effective tax rate. A complete reconciliation to
previously reported 2008 amounts is available on Colgate’s web site.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP measures used
in this earnings release:
To supplement Colgate's condensed consolidated income statements
presented in accordance with accounting principles generally accepted in
the United States of America (GAAP), the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Gross profit
margin, selling, general and administrative expenses, operating profit,
operating profit margin, net income and earnings per share are discussed
in this release both as reported (on a GAAP basis) and excluding the
impact of restructuring charges related to the restructuring program
that began in the fourth quarter of 2004 and was completed as of the end
of 2008 (the "2004 Restructuring Program"). These restructuring charges
include separation-related costs, incremental depreciation and asset
write-downs, and other costs related to the implementation of the 2004
Restructuring Program. In light of their nature and magnitude, the
Company believes these items should be presented separately to enhance
an investor’s overall understanding of its ongoing operations.
Management believes these non-GAAP financial measures provide useful
supplemental information to investors regarding the underlying business
trends and performance of the Company’s ongoing operations and are
useful for period-over-period comparisons of such operations. The
Company uses these financial measures internally in its budgeting
process and as factors in determining compensation. While the Company
believes that these financial measures are useful in evaluating the
Company’s business, this information should be considered as
supplemental in nature and is not meant to be considered in isolation or
as a substitute for the related financial information prepared in
accordance with GAAP. In addition, these non-GAAP financial measures may
not be the same as similar measures presented by other companies. See
“Consolidated Income Statement and Supplemental Information —
Reconciliation Excluding the 2004 Restructuring Program” for the three
months ended June 30, 2009 and 2008 included with this release for a
reconciliation of these financial measures to the related GAAP measures.
Sales and unit volume growth, both worldwide and in relevant geographic
divisions, are discussed in this release both as reported and excluding
divestments. Management believes this provides useful supplemental
information to investors as it allows comparisons of sales growth and
volume growth from ongoing operations on a period-over-period basis.
This release also discusses organic sales growth (excludes the impact of
foreign exchange, acquisitions and divestments). Management believes
this measure provides investors with useful supplemental information
regarding the Company’s underlying sales trends by presenting sales
growth excluding the external factor of foreign exchange as well as the
impact from acquisitions and divestments. See “Geographic Sales
Analysis, Percentage Changes – Second Quarter 2009 vs. 2008” for a
comparison of sales excluding divestments and organic sales to sales as
reported in accordance with GAAP.
The Company defines free cash flow before dividends as net cash provided
by operations less capital expenditures. As management uses this measure
to evaluate the Company’s ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See “Condensed Consolidated Statements of
Cash Flows For the Six Months Ended June 30, 2009 and 2008” for a
comparison of free cash flow before dividends to net cash provided by
operations as reported in accordance with GAAP.
(See attached tables for second quarter results.)
|
Table 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
Consolidated Income Statement and Supplemental Information
|
|
|
|
|
|
Reconciliation Excluding the 2004 Restructuring Program
|
|
|
|
|
|
For the Three Months Ended June 30, 2009 and 2008
|
|
|
|
|
|
(in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
|
|
|
As Reported
|
|
As Reported
|
|
Restructuring
|
|
Excluding Restructuring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
3,745.0
|
|
|
$
|
3,964.8
|
|
|
$
|
-
|
|
|
$
|
3,964.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
1,543.8
|
|
|
|
1,725.0
|
|
|
|
11.0
|
|
|
|
1,714.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
2,201.2
|
|
|
|
2,239.8
|
|
|
|
(11.0
|
)
|
|
|
2,250.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
58.8
|
%
|
|
|
56.5
|
%
|
|
|
|
|
56.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
1,295.7
|
|
|
|
1,422.7
|
|
|
|
20.7
|
|
|
|
1,402.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
18.4
|
|
|
|
28.7
|
|
|
|
7.2
|
|
|
|
21.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
887.1
|
|
|
|
788.4
|
|
|
|
(38.9
|
)
|
|
|
827.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
23.7
|
%
|
|
|
19.9
|
%
|
|
|
|
|
20.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
21.5
|
|
|
|
25.4
|
|
|
|
-
|
|
|
|
25.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
865.6
|
|
|
|
763.0
|
|
|
|
(38.9
|
)
|
|
|
801.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
277.8
|
|
|
|
247.8
|
|
|
|
(9.4
|
)
|
|
|
257.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
32.1
|
%
|
|
|
32.5
|
%
|
|
|
|
|
32.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
587.8
|
|
|
|
515.2
|
|
|
|
(29.5
|
)
|
|
|
544.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests*
|
|
|
26.2
|
|
|
|
21.4
|
|
|
|
-
|
|
|
|
21.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
561.6
|
|
|
|
493.8
|
|
|
|
(29.5
|
)
|
|
|
523.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.11
|
|
|
$
|
0.96
|
|
|
$
|
(0.06
|
)
|
|
$
|
1.02
|
|
|
|
Diluted
|
|
$
|
1.07
|
|
|
$
|
0.92
|
|
|
$
|
(0.06
|
)
|
|
$
|
0.98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
500.1
|
|
|
|
507.1
|
|
|
|
507.1
|
|
|
|
507.1
|
|
|
|
Diluted
|
|
|
524.9
|
|
|
|
536.6
|
|
|
|
536.6
|
|
|
|
536.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of
ARB No. 51” (SFAS 160), on January 1, 2009. To conform to the
current year's presentation, net income attributable to
noncontrolling interests in less-than-wholly-owned subsidiaries
has been reclassified from Other (income) expense, net to a new
line below Operating profit called Net income attributable to
noncontrolling interests. The reclassification had no effect on
Net income or Earnings per common share.
|
|
|
|
|
|
|
Refer to the Company's web site for a reconciliation to previously
reported amounts for all quarters of 2008 as well as full year
2008 and 2007.
|
|
|
|
|
|
|
|
Note: The impact of "Restructuring” on the basic and diluted
earnings per share may not necessarily equal the earnings per
share if calculated independently as a result of rounding.
|
|
|
Table 2
|
|
Colgate-Palmolive Company
|
|
|
|
Consolidated Income Statement and Supplemental Information
|
|
|
|
Reconciliation Excluding the 2004 Restructuring Program
|
|
|
|
For the Six Months Ended June 30, 2009 and 2008
|
|
|
|
(in Millions Except Per Share Amounts) (Unaudited)
|
|
|
|
|
|
|
|
2009
|
|
2008
|
|
|
|
As Reported
|
|
As Reported
|
|
Restructuring
|
|
Excluding Restructuring
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
7,247.8
|
|
$
|
7,677.8
|
|
$
|
-
|
|
|
$
|
7,677.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
3,034.2
|
|
|
3,338.2
|
|
|
36.9
|
|
|
|
3,301.3
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
4,213.6
|
|
|
4,339.6
|
|
|
(36.9)
|
|
|
|
4,376.5
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
58.1%
|
|
|
56.5%
|
|
|
|
|
|
57.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
2,481.4
|
|
|
2,771.6
|
|
|
33.9
|
|
|
|
2,737.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (income) expense, net
|
|
|
33.7
|
|
|
33.9
|
|
|
6.5
|
|
|
|
27.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
|
|
|
1,698.5
|
|
|
1,534.1
|
|
|
(77.3)
|
|
|
|
1,611.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit margin
|
|
|
23.4%
|
|
|
20.0%
|
|
|
|
|
|
21.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
42.7
|
|
|
59.1
|
|
|
-
|
|
|
|
59.1
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
1,655.8
|
|
|
1,475.0
|
|
|
(77.3)
|
|
|
|
1,552.3
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
531.5
|
|
|
471.3
|
|
|
(26.6)
|
|
|
|
497.9
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
32.1%
|
|
|
32.0%
|
|
|
|
|
|
32.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income including noncontrolling interests
|
|
|
1,124.3
|
|
|
1,003.7
|
|
|
(50.7)
|
|
|
|
1,054.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to noncontrolling interests*
|
|
54.8
|
|
|
43.4
|
|
|
-
|
|
|
|
43.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1,069.5
|
|
|
960.3
|
|
|
(50.7)
|
|
|
|
1,011.0
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.11
|
|
$
|
1.86
|
|
$
|
(0.10)
|
|
|
$
|
1.96
|
|
Diluted
|
|
$
|
2.04
|
|
$
|
1.78
|
|
$
|
(0.10)
|
|
|
$
|
1.88
|
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
500.8
|
|
|
508.1
|
|
|
508.1
|
|
|
|
508.1
|
|
Diluted
|
|
|
525.4
|
|
|
538.0
|
|
|
538.0
|
|
|
|
538.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of
ARB No. 51” (SFAS 160), on January 1, 2009. To conform to the
current year's presentation, net income attributable to
noncontrolling interests in less-than-wholly-owned subsidiaries
has been reclassified from Other (income) expense, net to a new
line below Operating profit called Net income attributable to
noncontrolling interests. The reclassification had no effect on
Net income or Earnings per common share.
|
|
|
|
|
|
|
|
|
|
|
|
|
Refer to the Company's web site for a reconciliation to previously
reported amounts for all quarters of 2008 as well as full year 2008
and 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
Note: The impact of "Restructuring” on the basic and diluted
earnings per share may not necessarily equal the earnings per share
if calculated independently as a result of rounding.
|
|
|
|
|
|
|
|
|
|
Table 3
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2009, December 31, 2008 and June 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2009
|
|
December 31, 2008
|
|
June 30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
896.0
|
|
$
|
554.9
|
|
$
|
622.8
|
|
|
|
Receivables, net
|
|
|
1,727.8
|
|
|
1,591.9
|
|
|
1,872.5
|
|
|
|
Inventories
|
|
|
1,223.8
|
|
|
1,197.1
|
|
|
1,340.5
|
|
|
|
Other current assets
|
|
|
370.2
|
|
|
366.1
|
|
|
421.4
|
|
|
|
Property, plant and equipment, net
|
|
|
3,245.4
|
|
|
3,119.5
|
|
|
3,149.3
|
|
|
|
Other assets, including goodwill and intangibles
|
|
|
3,266.9
|
|
|
3,149.8
|
|
|
3,663.8
|
|
|
|
Total assets
|
|
$
|
10,730.1
|
|
$
|
9,979.3
|
|
$
|
11,070.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt
|
|
|
3,801.8
|
|
|
3,783.5
|
|
|
3,730.5
|
|
|
|
Other current liabilities
|
|
|
2,806.3
|
|
|
2,755.1
|
|
|
3,065.7
|
|
|
|
Other non-current liabilities**
|
|
|
1,423.0
|
|
|
1,397.4
|
|
|
1,461.3
|
|
|
|
Total liabilities
|
|
|
8,031.1
|
|
|
7,936.0
|
|
|
8,257.5
|
|
|
|
Total Colgate-Palmolive Company shareholders' equity
|
|
|
2,540.3
|
|
|
1,922.1
|
|
|
2,666.6
|
|
|
|
Noncontrolling interests**
|
|
|
158.7
|
|
|
121.2
|
|
|
146.2
|
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
10,730.1
|
|
$
|
9,979.3
|
|
$
|
11,070.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Balance Sheet Information
|
|
|
|
|
|
|
|
|
|
Debt less cash, cash equivalents and marketable securities*
|
|
$
|
2,873.3
|
|
$
|
3,216.4
|
|
$
|
3,087.0
|
|
|
|
Working capital % of sales
|
|
|
3.2%
|
|
|
2.5%
|
|
|
3.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Marketable securities of $32.5, $12.2 and $20.7 as of June 30,
2009, December 31, 2008 and June 30, 2008, respectively, are
included in Other current assets.
|
|
|
|
|
|
|
|
|
|
|
|
** The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of
ARB No. 51” (SFAS 160), on January 1, 2009. To conform to the
current year's presentation, prior period balances of accumulated
undistributed earnings relating to noncontrolling interests in
less-than-wholly-owned subsidiaries have been reclassified from
Other non-current liabilities to a component of shareholders'
equity.
Refer to the Company's web site for a reconciliation to previously
reported amounts for all quarters of 2008 as well as full year
2008 and 2007.
|
|
|
|
|
|
|
Table 4
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
2008*
|
|
|
|
|
|
|
|
|
Operating Activities
|
|
|
|
|
|
Net income
|
$ 1,069.5
|
|
$ 960.3
|
|
|
Adjustments to reconcile net income to net cash provided by
operations:
|
|
|
|
|
|
Restructuring, net of cash
|
(9.0)
|
|
(47.1)
|
|
|
Depreciation and amortization
|
172.1
|
|
172.4
|
|
|
Stock-based compensation expense
|
55.7
|
|
42.7
|
|
|
Deferred income taxes
|
33.9
|
|
67.0
|
|
|
Cash effects of changes in:
|
|
|
|
|
|
|
Receivables
|
(86.1)
|
|
(132.5)
|
|
|
|
Inventories
|
1.8
|
|
(135.2)
|
|
|
|
Accounts payable and other accruals
|
(61.6)
|
|
59.8
|
|
|
|
Other non-current assets and liabilities
|
34.4
|
|
49.0
|
|
|
|
Net cash provided by operations
|
1,210.7
|
|
1,036.4
|
|
|
|
|
|
|
|
|
Investing Activities
|
|
|
|
|
|
Capital expenditures
|
(210.1)
|
|
(216.7)
|
|
|
Sale of property and non-core product lines
|
12.4
|
|
44.9
|
|
|
Other
|
|
(19.0)
|
|
0.8
|
|
|
|
Net cash used in investing activities
|
(216.7)
|
|
(171.0)
|
|
|
|
|
|
|
|
|
Financing Activities
|
|
|
|
|
|
Principal payments on debt
|
(1,514.9)
|
|
(1,380.8)
|
|
|
Proceeds from issuance of debt
|
1,607.8
|
|
1,542.9
|
|
|
Dividends paid
|
(454.1)
|
|
(409.7)
|
|
|
Purchases of treasury shares
|
(395.7)
|
|
(542.0)
|
|
|
Proceeds from exercise of stock options and excess tax benefits
|
92.1
|
|
117.1
|
|
|
|
Net cash used in financing activities
|
(664.8)
|
|
(672.5)
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on Cash and cash equivalents
|
11.9
|
|
1.2
|
|
Net increase in Cash and cash equivalents
|
341.1
|
|
194.1
|
|
Cash and cash equivalents at beginning of period
|
554.9
|
|
428.7
|
|
Cash and cash equivalents at end of period
|
$ 896.0
|
|
$ 622.8
|
|
|
|
|
|
|
|
|
Supplemental Cash Flow Information
|
|
|
|
|
Free cash flow before dividends (Net cash provided by operations
less capital expenditures)
|
|
|
|
|
|
Net cash provided by operations
|
$ 1,210.7
|
|
$ 1,036.4
|
|
|
Less: Capital expenditures
|
(210.1)
|
|
(216.7)
|
|
Free cash flow before dividends
|
$ 1,000.6
|
|
$ 819.7
|
|
|
|
|
|
|
|
|
Income taxes paid
|
$ 582.1
|
|
$ 399.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Certain relcassifications have been made to prior year amounts
to conform to the current year's presentation as a result of the
adoption on January 1, 2009 of FASB Statement No. 160,
“Noncontrolling Interests in Consolidated Financial Statements -
An Amendment of ARB No. 51”.
|
|
|
|
|
|
|
|
|
|
Table 5
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
Segment Information
|
|
|
|
|
|
|
|
|
|
|
|
For the Three and Six Months Ended June 30, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
(Dollars in Millions) (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
2009
|
|
2008
|
|
2009
|
|
2008
|
|
Net sales
|
|
|
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
$
|
734.4
|
|
|
$
|
715.1
|
|
|
$
|
1,464.1
|
|
|
$
|
1,424.6
|
|
|
|
Latin America
|
|
1,050.0
|
|
|
|
1,065.1
|
|
|
|
1,961.0
|
|
|
|
2,010.6
|
|
|
|
Europe/South Pacific
|
|
790.5
|
|
|
|
966.7
|
|
|
|
1,509.6
|
|
|
|
1,866.7
|
|
|
|
Greater Asia/Africa
|
|
640.2
|
|
|
|
670.4
|
|
|
|
1,276.8
|
|
|
|
1,325.2
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
3,215.1
|
|
|
|
3,417.3
|
|
|
|
6,211.5
|
|
|
|
6,627.1
|
|
|
|
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
529.9
|
|
|
|
547.5
|
|
|
|
1,036.3
|
|
|
|
1,050.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Net sales
|
$
|
3,745.0
|
|
|
$
|
3,964.8
|
|
|
$
|
7,247.8
|
|
|
$
|
7,677.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|
|
|
2009
|
|
2008
|
|
2009
|
|
2008
|
|
Operating profit
|
|
|
|
|
|
|
|
|
Oral, Personal and Home Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
$
|
199.5
|
|
|
$
|
169.8
|
|
|
$
|
391.1
|
|
|
$
|
333.9
|
|
|
|
Latin America
|
|
334.9
|
|
|
|
294.5
|
|
|
|
641.1
|
|
|
|
574.5
|
|
|
|
Europe/South Pacific
|
|
177.2
|
|
|
|
202.1
|
|
|
|
320.3
|
|
|
|
394.5
|
|
|
|
Greater Asia/Africa*
|
|
144.8
|
|
|
|
126.5
|
|
|
|
296.4
|
|
|
|
254.2
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Oral, Personal and Home Care
|
|
856.4
|
|
|
|
792.9
|
|
|
|
1,648.9
|
|
|
|
1,557.1
|
|
|
|
|
|
|
|
|
|
|
|
|
Pet Nutrition
|
|
139.4
|
|
|
|
129.9
|
|
|
|
271.1
|
|
|
|
257.3
|
|
|
Corporate
|
|
(108.7
|
)
|
|
|
(134.4
|
)
|
|
|
(221.5
|
)
|
|
|
(280.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Total Operating Profit
|
$
|
887.1
|
|
|
$
|
788.4
|
|
|
$
|
1,698.5
|
|
|
$
|
1,534.1
|
|
|
|
|
|
|
|
|
|
|
|
|
* The Company adopted FASB Statement No. 160, “Noncontrolling
Interests in Consolidated Financial Statements - An Amendment of
ARB No. 51” (SFAS 160), on January 1, 2009. To conform to the
current year's presentation, the amounts of net income
attributable to noncontrolling interests in less-than-wholly-owned
subsidiaries of $21.4 and $43.4 for the three and six months ended
June 30, 2008, respectively, which were previously deducted from
Greater Asia/Africa Operating profit, have been reclassified to a
new line below Operating profit.
|
|
|
|
Note: The Company evaluates segment performance based on several
factors, including Operating profit. The Company uses Operating
profit as a measure of the operating segment performance because
it excludes the impact of corporate-driven decisions related to
interest expense and income taxes. Corporate operations include
restructuring and related implementation costs, stock-based
compensation related to stock options and restricted stock awards,
research and development costs, Corporate overhead costs, and
gains and losses on sales of non-core product lines and assets.
For the three and six months ended June 30, 2008, Corporate
operating expenses include $38.9 and $77.3 of charges related to
the Company’s 2004 Restructuring Program, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 6
|
|
Colgate-Palmolive Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Sales Analysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage Changes - Second Quarter 2009 vs 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE SECOND QUARTER
|
|
|
|
|
|
|
|
|
COMPONENTS OF SALES CHANGE SIX MONTHS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
Coupons
Consumer &
Trade
Incentives
|
|
|
|
|
|
|
|
|
|
|
|
|
Pricing
Coupons
Consumer &
Trade
Incentives
|
|
|
|
Region
|
|
2nd Qtr
Sales
Change
As Reported
|
|
2nd Qtr
Sales
Change
Ex-Divestment
|
|
2nd Qtr
Organic
Sales Change
|
|
Ex-Divested
Volume
|
|
|
Exchange
|
|
|
6 Months
Sales
Change
As Reported
|
|
6 Months
Sales
Change
Ex-Divestment
|
|
6 Months
Organic
Sales Change
|
|
Ex-Divested
Volume
|
|
|
Exchange
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company
|
(5.5%)
|
|
(5.5%)
|
|
6.0%
|
|
(1.5%)
|
|
7.5%
|
|
(11.5%)
|
|
|
(5.5%)
|
|
(5.5%)
|
|
7.0%
|
|
(1.0%)
|
|
8.0%
|
|
(12.5%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe/South Pacific
|
(18.0%)
|
|
(17.5%)
|
|
(1.5%)
|
|
(2.5%)
|
|
1.0%
|
|
(16.0%)
|
|
|
(19.0%)
|
|
(18.5%)
|
|
(1.5%)
|
|
(3.0%)
|
|
1.5%
|
|
(17.0%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latin America
|
|
(1.5%)
|
|
(1.5%)
|
|
16.5%
|
|
2.0%
|
|
14.5%
|
|
(18.0%)
|
|
|
(2.5%)
|
|
(2.5%)
|
|
16.5%
|
|
2.0%
|
|
14.5%
|
|
(19.0%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greater Asia/Africa
|
(4.5%)
|
|
(4.0%)
|
|
8.0%
|
|
(1.0%)
|
|
9.0%
|
|
(12.0%)
|
|
|
(3.5%)
|
|
(3.5%)
|
|
9.5%
|
|
1.5%
|
|
8.0%
|
|
(13.0%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International
|
(8.0%)
|
|
(7.5%)
|
|
8.0%
|
|
(0.5%)
|
|
8.5%
|
|
(15.5%)
|
|
|
(9.0%)
|
|
(8.5%)
|
|
8.0%
|
|
0.0%
|
|
8.0%
|
|
(16.5%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
North America
|
|
2.5%
|
|
2.5%
|
|
4.0%
|
|
2.5%
|
|
1.5%
|
|
(1.5%)
|
|
|
3.0%
|
|
3.0%
|
|
4.5%
|
|
2.5%
|
|
2.0%
|
|
(1.5%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CP Products
|
(6.0%)
|
|
(5.5%)
|
|
7.5%
|
|
0.5%
|
|
7.0%
|
|
(13.0%)
|
|
|
(6.5%)
|
|
(6.0%)
|
|
7.5%
|
|
0.5%
|
|
7.0%
|
|
(13.5%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hill's
|
|
(3.0%)
|
|
(3.0%)
|
|
1.0%
|
|
(11.5%)
|
|
12.5%
|
|
(4.0%)
|
|
|
(1.5%)
|
|
(1.5%)
|
|
3.5%
|
|
(9.5%)
|
|
13.0%
|
|
(5.0%)
|
Colgate-Palmolive Company
Bina Thompson, 212-310-3072
Hope
Spiller, 212-310-2291